Research Grant
[Cite as http://purl.org/au-research/grants/nhmrc/1081221]Brief description Current treatments only cure 50% of Acute Myeloid Leukaemia (AML) patients, and novel approaches to treatment are desperately needed to improve survival of patients with leukaemia. One new drug, Birinapant, is currently being tested in clinical trials to treat AML. I have found that some AMLs are resistant to Birinapant treatment but the addition of a second drug (called “p38 inhibitors”) can now overcome this resistance. I will test how effective combining these two drugs can be to treat AML.
Funding Amount $AUD 200,890.62
Funding Scheme Project Grants
Notes New Investigator Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1081221
- nhmrc : 1081221